DCALPharmaceuticals
Dishman Carbogen Amcis Ltd — Cash Flow Statement
₹129.97
-7.38%
Dishman Carbogen Amcis Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Change In Inventory | -24.47 Cr | -85.24 Cr | -158.68 Cr | -143.30 Cr | — |
| Change In Receivables | -181.12 Cr | 123.49 Cr | -119.64 Cr | -59.36 Cr | — |
| Other Non Cash Items | 170.06 Cr | 113.11 Cr | 108.86 Cr | 29.00 Cr | — |
| Provisionand Write Offof Assets | 1.01 Cr | 9.53 Cr | -0.20 Cr | -5.23 Cr | — |
| Depreciation And Amortization | 293.74 Cr | 310.86 Cr | 280.72 Cr | 307.59 Cr | — |
| Depreciation | 293.74 Cr | 310.86 Cr | 217.54 Cr | 207.04 Cr | — |
| Gain Loss On Investment Securities | -1.12 Cr | -1.91 Cr | -0.32 Cr | -4.77 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 2.10 Cr | -60.15 Cr | -0.46 Cr | 2.56 Cr | — |
| Gain Loss On Sale Of PPE | 1.04 Cr | 5.39 Cr | 3.57 Cr | 1.93 Cr | — |
| Net Income From Continuing Operations | 19.31 Cr | -122.26 Cr | -54.59 Cr | -4.25 Cr | — |
| Free Cash Flow | 158.47 Cr | 76.18 Cr | -353.73 Cr | -108.95 Cr | — |
| Repayment Of Debt | -109.55 Cr | -97.80 Cr | -165.68 Cr | -166.67 Cr | — |
| Issuance Of Debt | 283.07 Cr | 148.24 Cr | 332.19 Cr | 448.67 Cr | — |
| Capital Expenditure | -216.76 Cr | -303.25 Cr | -619.68 Cr | -463.80 Cr | — |
| End Cash Position | 341.07 Cr | 264.09 Cr | 131.79 Cr | 110.24 Cr | — |
| Beginning Cash Position | 264.09 Cr | 131.79 Cr | 110.24 Cr | 243.54 Cr | — |
| Effect Of Exchange Rate Changes | -3.95 Cr | 4.54 Cr | — | — | — |
| Changes In Cash | 80.93 Cr | 127.76 Cr | 21.54 Cr | -133.31 Cr | — |
| Financing Cash Flow | -102.09 Cr | -22.15 Cr | 249.67 Cr | 130.37 Cr | — |
| Interest Paid Cff | -150.96 Cr | -98.63 Cr | -73.28 Cr | -59.79 Cr | — |
| Net Issuance Payments Of Debt | 78.79 Cr | 119.26 Cr | 354.91 Cr | 216.82 Cr | — |
| Net Short Term Debt Issuance | -94.73 Cr | 68.82 Cr | 188.40 Cr | -65.18 Cr | — |
| Net Long Term Debt Issuance | 173.52 Cr | 50.44 Cr | 166.51 Cr | 282.00 Cr | — |
| Long Term Debt Payments | -109.55 Cr | -97.80 Cr | -165.68 Cr | -166.67 Cr | — |
| Long Term Debt Issuance | 283.07 Cr | 148.24 Cr | 332.19 Cr | 448.67 Cr | — |
| Investing Cash Flow | -192.21 Cr | -229.52 Cr | -494.08 Cr | -618.53 Cr | — |
| Interest Received Cfi | 2.23 Cr | 12.13 Cr | 15.60 Cr | 27.12 Cr | — |
| Net Investment Purchase And Sale | -24.74 Cr | 61.47 Cr | 108.81 Cr | -171.15 Cr | — |
| Purchase Of Investment | -24.74 Cr | -88.42 Cr | -12.34 Cr | -171.15 Cr | — |
| Net PPE Purchase And Sale | -215.47 Cr | -303.12 Cr | -618.20 Cr | -455.47 Cr | — |
| Sale Of PPE | 1.29 Cr | 0.13 Cr | 1.48 Cr | 8.33 Cr | — |
| Purchase Of PPE | -216.76 Cr | -303.25 Cr | -619.68 Cr | -463.80 Cr | — |
| Operating Cash Flow | 375.23 Cr | 379.43 Cr | 265.95 Cr | 354.85 Cr | — |
| Taxes Refund Paid | -30.32 Cr | -18.97 Cr | -34.18 Cr | -56.33 Cr | — |
| Change In Working Capital | -80.59 Cr | 143.83 Cr | -37.73 Cr | 90.08 Cr | — |
| Change In Other Current Assets | -2.55 Cr | 17.49 Cr | 32.51 Cr | 57.03 Cr | — |
| Change In Payable | 127.55 Cr | 88.09 Cr | 208.08 Cr | 235.71 Cr | — |
| Amortization Cash Flow | — | 58.75 Cr | 63.18 Cr | 100.55 Cr | 103.38 Cr |
| Sale Of Investment | — | 149.89 Cr | 121.15 Cr | — | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | — | 0.01 Cr | 0.01 Cr | — |
| Net Other Investing Changes | — | — | 5.27 Cr | -21.83 Cr | -20.99 Cr |
| Repurchase Of Capital Stock | — | — | — | 0.00 | -2.31 Cr |
| Net Common Stock Issuance | — | — | — | 0.00 | -2.31 Cr |
| Common Stock Payments | — | — | — | 0.00 | -2.31 Cr |
| Common Stock Dividend Paid | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Dishman Carbogen Amcis Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.